Document is current
Any future updates will be listed below
-
Authors
Araujo Tavares, Rafael de Cesaris https://orcid.org/0000-0003-0278-1528
Dhir, Somdutta
He, Xuan https://orcid.org/0009-0004-4589-675X
Monahan, Jack https://orcid.org/0000-0002-0635-0015
Taipale, Minna
Golder, Paula
Ciau-Uitz, Aldo https://orcid.org/0000-0002-0505-6607
Gosal, Walraj
Tannahill, David https://orcid.org/0000-0002-3811-6864
Balasubramanian, Shankar https://orcid.org/0000-0002-0281-5815
-
Funding
Funding for this research was provided by:
Cancer Research UK (Core funding (C9681/A29214))
Cancer Research UK (Programme grant)
Wellcome Trust (209441/Z/17/Z)
- License Information
-
More Information
Article History
Received: 17 June 2025
Accepted: 2 February 2026
First Online: 10 February 2026
Competing interests
: S.B. is a founder and shareholder of biomodal Ltd, GenomeTx and RNAvate Ltd and a science partner and paid adviser to Ahren Innovation Capital LLC. J.M., M.T., P.G., A.C-U., and W.G. are employees of biomodal Ltd. The remaining authors declare no competing interests.
